Monthly Archives: March 2019

As an opioid crisis drives the spread of HIV, Kentucky plan invests in harm reduction, training, care and community

By on .

Using funds generated by Kentucky’s HIV drug assistance program, a plan launched this month will support urgent and ongoing responses to the infectious disease impacts of an injecting drug use epidemic From all the evidence that Dr. Alice Thornton and her colleagues could see in the growing numbers of patients coming through the doors of […]

Reaffirming support for widely expanded global gag rule, Sec. Pompeo denies policy has affected global health responses, and adds restrictions

By on .

Claiming that the “vast majority of our implementing partners have agreed to comply” with the policy expanded by President Trump banning any U.S.-funded overseas organization from providing any information, services or referrals to terminate a pregnancy, Secretary of State Michael Pompeo this morning reiterated administration support for the restriction widely known as “the Global Gag […]

What we’re reading: It is past time to end the impacts of tuberculosis

By on .

India should heed a teenager’s historic fight for lifesaving tuberculosis treatment – The grotesque story told here of how a bureaucratic technicality was allowed to stand between a teenage girl and the cure she needed for drug-resistant tuberculosis can be seen as a microcosm of larger scale failures to conquer an ancient disease by sharing […]

CDC U.S., global TB data highlight worldwide needs for extended screening, preventive treatment, access to newest medicines

By on .

Releasing the most recent domestic and global data on tuberculosis incidence in this week’s Morbidity and Mortality Weekly Report, the U.S. Centers for Disease Control and Prevention emphasized that while rates of new cases continue to drop, they are not declining swiftly enough to reach important and achievable goals. Those goals include ones agreed to […]

WHO finalizes MDR-TB treatment guidance recommending shift from injections

By on .

Including recommendations that injected drugs with permanent debilitating side effects not be included in longer treatment regimens against multidrug-resistant tuberculosis, and the inclusion of the most recently added drugs, bedaquiline and delamanid in those treatments, the World Health Organization today released updated guidelines for treating TB that does not respond to first line treatments. The […]

CUGH 2019: Researchers say training, resources for the “private sector,” including traditional healers, will be critical to TB control

By on .

CHICAGO – To find the missing tuberculosis cases that go unreported each year, national TB programs will have to reach out to the places where the most people seek care, researchers said here. And that’s not in public hospitals or clinics where capacities to respond to TB already exist, but in the private sector in […]

STREAM Trial: Nine-month regimen for drug-resistant tuberculosis brings “promising cure rates”

By on .

A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the World Health Organization in 2011 guidelines, substantiates earlier observed findings showing comparable success rates between the two. The STREAM trial (Standard Treatment Regimen of Anti-Tuberculosis drugs for patients with […]

What we’re reading: Thoughts on the White House budget proposal against a plan to eliminate U.S. HIV incidence

By on .

Since the president’s Feb. 5 State of the Union address pledge to end transmissions of HIV in the United States in the next 10 years, and the release of a strategy the next day outlining plans to target the hardest hit counties and states, the most critical immediate unanswered questions have concerned funding for the […]

CROI 2019: PopART HIV prevention study brings confirmation but also questions

By on .

Door-to-door HIV counseling and testing, followed by immediate access to treatment led to incidence drops — but with a caveat . . . SEATTLE – When the PopART study began in Zambia and  South Africa five years ago, the measures it would test among roughly a million people were so obviously beneficial, that the results […]

CROI 2019: Will the “Düsseldorf patient” make three — further propelling cure research?

By on .

Five years after a stem cell transplant with the same critical factor as those received by the Berlin patient and the London patient, and four months after stopping antiretroviral treatment, a Düsseldorf man remains virally suppressed SEATTLE – Exemplifying both the caution and the optimism essential to HIV cure science, Dr. Björn-Erik Ole Jensen won’t […]